About: Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.14 (-0.21%)
VANI NASDAQ Vivani Medical Inc.
Vivani Medical Inc. share price
Atividade de preço de VANI
Último preço
$ 1,140
Variação (24h)
-0,00 USD (0,21%)
Volume
185.36K
Volume (média 4 sem.)
-
Abertura
$ 1,13
Variação do dia
$ 1,12 - $ 1,20
Fechamento anterior
$ 1,14
Último negócio
29 Oct, 7:50 pm GMT+0
Atrasado
29 Oct, 7:50 pm GMT+0
VANI price performance
Atrasado
29 Oct, 7:50 pm GMT+0
quote.marketSignals